Sign In
Buy CCXI
$13.86
-0.140 (-1.00%)
At Close: Jul 31, 2026
Agility Robotics Strengthens Executive Leadership Team with Appointment of Michael Beer as Chief Financial Officer
08:00am, Thursday, 23'rd Jul 2026
Experienced public company finance executive joins Agility as company expands commercial momentum and prepares to become the first publicly listed U.S. pure-play humanoid robotics company. SALEM, Ore.
Agility Opens New Fremont Facility to Accelerate Physical AI Development
03:00pm, Thursday, 16'th Jul 2026
Bay Area facility will advance the AI technologies that enable its humanoid robot, Digit, to learn new skills, supporting expanded capabilities across commercial deployments. FREMONT, Calif.
Agility Robotics, Inc. (âAgilityâ or the âCompanyâ) creator of the general-purpose humanoid robot Digit, and Churchill Capital Corp XI (NASDAQ: CCXI) (
SALEM, Ore. & NEW YORK--(BUSINESS WIRE)--Agility Robotics, Inc. (“Agility” or the “Company”) creator of the general-purpose humanoid robot Digit, and Churchill Capital Corp XI (NASDAQ: CCXI) (
Churchill Capital Stock Is Surging Wednesday: What Investors Need to Know
09:18am, Wednesday, 01'st Jul 2026
Churchill Capital Corp XI (NASDAQ:CCXI) shares are up during Wednesday's premarket session, trading higher by almost 11% as traders continue to weigh the latest SEC filing details tied to its definiti
Humanoid robot startup Agility Robotics is going public at a $2.5 billion valuation via a SPAC
05:00pm, Wednesday, 24'th Jun 2026
Agility Robotics plans to go public via a SPAC at a $2.5 billion valuation. Agility has deployed Digit robots at Amazon, Toyota, and the logistics firm GXO.
Agility Robotics heads to Wall Street in a $2.5B bet on staffing warehouses with humanoids
04:40pm, Wednesday, 24'th Jun 2026
A maker of humanlike robots that carry totes around warehouses is going public on Wall Street in a test of whether there's a market for putting AI-powered humanoid machines to work.
Agility Robotics to Go Public Through $2.5 Billion Merger with Churchill Capital Corp XI
06:00am, Wednesday, 24'th Jun 2026
SALEM, Ore. & NEW YORK--(BUSINESS WIRE)--Agility Robotics, Inc. (“Agility” or the “Company”), a leading humanoid robotics and physical AI company, and Churchill Capital Corp XI (NASDAQ: CCXI)
Churchill Capital Corp XI Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 9, 2026
04:28pm, Thursday, 05'th Feb 2026
New York, NY, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Churchill Capital Corp XI (Nasdaq: CCXIU) (the “Company”) announced today that, commencing February 9, 2026, holders of the units sold in the Compan
AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX
09:05am, Thursday, 20'th Oct 2022
TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio THOUSAND OAKS, Calif. , Oct. 20, 2022 /PRNewswire/ -- Amgen
-- Planned posters and an oral presentation will highlight data from the trials that supported the approval of TAVNEOS ® (avacopan) for patients with ANCA-associated vasculitis; additional poster wil
Is ChemoCentryx (CCXI) Stock Outpacing Its Medical Peers This Year?
11:17am, Thursday, 06'th Oct 2022
Here is how ChemoCentryx (CCXI) and Eiger BioPharmaceuticals (EIGR) have performed compared to their sector so far this year.
-- Two poster presentations planned for CCX559, including results from ongoing Phase I clinical study in patients with advanced solid tumors, and preclinical evidence from murine model -- SAN CARLOS,
NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether certain directors and officer
Cancer-Drug Maker's Solid Position And Successful Drug Record Drive Growth
05:09pm, Thursday, 08'th Sep 2022
Cancer-drug maker Amgen solidified its position in a highly competitive market by acquiring its rival Mirati Therapeutics.
